BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$25.92 USD
+0.20 (0.78%)
Updated Sep 20, 2024 10:32 AM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
BLFS 25.92 +0.20(0.78%)
Will BLFS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BLFS
Here's What Could Help BioLife Solutions (BLFS) Maintain Its Recent Price Strength
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Tops Revenue Estimates
Envista (NVST) Q2 Earnings and Revenues Lag Estimates
Owens & Minor (OMI) Q2 Earnings and Revenues Surpass Estimates
Other News for BLFS
BioLife Solutions management to meet with Stephens
BioLife Solutions Inc (BLFS) Shares Gap Down to $24.49 on Sep 17
BioLife Solutions management to meet with Stephens
What's Driving AtriCure Inc's Surprising 19% Stock Rally?
Conestoga Capital Advisors Q2 2024 Commentary